Chemotherapy extravasation: Establishing a national benchmark for incidence among cancer centers Journal Article


Authors: Jackson-Rose, J.; Del Monte, J.; Groman, A.; Dial, L. S.; Atwell, L.; Graham, J.; O'Neil Semler, R.; O'Sullivan, M.; Truini-Pittman, L.; Cunningham, T. A.; Roman-Fischetti, L.; Costantinou, E.; Rimkus, C.; Banavage, A. J.; Dietz, B.; Colussi, C. J.; Catania, K.; Wasko, M.; Schreffler, K. A.; West, C.; Siefert, M. L.; Rice, R. D.
Article Title: Chemotherapy extravasation: Establishing a national benchmark for incidence among cancer centers
Abstract: Background: Given the high-risk nature and nurse sensitivity of chemotherapy infusion and extravasation prevention, as well as the absence of an industry benchmark, a group of nurses studied oncology-specific nursing-sensitive indicators. Objectives: The purpose was to establish a benchmark for the incidence of chemotherapy extravasation with vesicants, irritants, and irritants with vesicant potential. Methods: Infusions with actual or suspected extravasations of vesicant and irritant chemotherapies were evaluated. Extravasation events were reviewed by type of agent, occurrence by drug category, route of administration, level of harm, follow-up, and patient referrals to surgical consultation. Findings: A total of 739,812 infusions were evaluated, with 673 extravasation events identified. Incidence for all extravasation events was 0.09%. © 2017 by the Oncology Nursing Society.
Keywords: chemotherapy; extravasation; irritant; vesicant
Journal Title: Clinical Journal of Oncology Nursing
Volume: 21
Issue: 4
ISSN: 1092-1095
Publisher: Oncology Nursing Society (ONS)  
Date Published: 2017-08-01
Start Page: 438
End Page: 445
Language: English
DOI: 10.1188/17.cjon.438-445
PROVIDER: scopus
PUBMED: 28738039
DOI/URL:
Notes: Article -- Export Date: 5 September 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rosemary O'Neil Semler
    9 Semler
  2. Judy M Graham
    2 Graham